IQVIA Holdings | IQV - Current Assets


IQVIA Holdings reported $6.23B in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Accenture USD 28.94B 931.01M Mar/2026
Agilent USD 4.76B 148M Mar/2026
Bruker USD 2.22B 121.4M Jun/2026
Cardinal Health USD 38.75B 689M Jun/2026
Celltrion KRW 481.57B 10.97B Mar/2026
Charles River Laboratories USD 1.53B 40.3M Jun/2026
Cigna USD 46.99B 3.96B Jun/2026
Cognizant Technology Solutions USD 7.56B 276M Jun/2026
Cspc Pharmaceutical CNY 22.25B 359.48M Dec/2025
CVS Health USD 75.35B 529M Jun/2026
Danaher USD 13.38B 554M Jun/2026
Dentsply International USD 1.93B 83M Jun/2026
Deva Holding AS TRY 9.13B 1.61B Sep/2023
Dianthus Therapeutics USD 897.54M 222.37M Jun/2026
Divis Laboratories Ltd INR 110.96B 12.53B Mar/2026
Elevance Health USD 67.18B 152M Jun/2026
Humana USD 38.08B 5.35B Mar/2026
IBM USD 28.4B 3.52B Jun/2026
Illumina USD 2.83B 96M Jun/2026
Infosys INR 2.5B 902.08B Mar/2026
Kangmei Pharma CNY 6.8B 225.83M Mar/2026
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Laboratorios Farma EUR 509.33M 128.63M Dec/2023
Laboratory Of America USD 3.81B 743.9M Jun/2026
Malin Corporation EUR 62.6M 26.7M Dec/2024
McKesson USD 62.84B 5.63B Jun/2026
Mettler Toledo International USD 1.35B 15.48M Jun/2026
Organigram Holdings CAD 250.09M 6.46M Mar/2026
Ovoca Bio EUR 2.07M 510K Dec/2025
Pharma Mar EUR 280.95M 7.5M Jun/2026
Publicis EUR 22.49B 575M Jun/2026
Qiagen NV USD 1.66B 116.37M Jun/2026
Quest Diagnostics USD 2.84B 278M Jun/2026
Revvity USD 2.3B 169.4M Jun/2026
Sartorius EUR 1.64B 280M Jun/2026
Sino Biopharmaceutical CNY 33.82B 9.13B Jun/2025
Thermo Fisher Scientific USD 23.36B 1.05B Jun/2026
Tilray USD 729.32M 28.18M Sep/2025
UnitedHealth USD 86.86B 4.27B Jun/2026
Veeva Systems USD 8.06B 65.63M Mar/2026
Veradigm USD 679.65M 131.12M Dec/2022
Waters USD 3.9B 186M Jun/2026
Zealand Pharma A/S 15.02B 652.12M Mar/2026
Zz Pientze Pharmaceu CNY 11.43B 728.95M Mar/2026